SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics ($MLTX) is trending due to a significant stock drop following analyst downgrades and concerns over clinical trial data for their drug, sonelokimab, with RBC Capital citing uncompetitive effect size. The community is debating whether the sell-off is an overreaction, with some seeing a buying opportunity due to the company's cash reserves and pipeline, while others express concern over biotech volatility and potential risks. Discussions also include speculation about potential buyouts and the impact of institutional ownership on the stock's price movement.

"What's Updog?" is a Community Led token.

UpDog

$UPDOG.X is trending, with the community actively engaging in the 'What's UpDog?' joke and highlighting its presence on the $SOL.X network. Community members emphasize that it's been active for over a year and is listed on Jupiter Strict List while also congratulating other trending tickers on being UpDog. The coin is also associated with meme culture, with many users sharing related content and humor.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

$WEEDCOIN.X is trending as community members rally around the crypto's connection to cannabis culture and a shared vision of positivity. Advocates emphasize that $WEEDCOIN.X represents more than just a token; it's a movement towards freedom, community, and growth, aiming to bridge the gap between cannabis enthusiasts and the digital economy.

Larimar Therapeutics, Inc. Is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics mitochondrial disorders and Friedreich's ataxia. The company was founded in 2005 and is headquartered in Bala Cynwyd, PA.

Larimar Therapeutics Inc

Larimar Therapeutics is trending as investors anticipate data from its nomlabofusp clinical development program for Friedreich's Ataxia, expected sometime this month. Community members are weighing the potential for positive results and a subsequent rise in stock price, while also considering the risk of negative outcomes given the high short interest and upcoming conference call to discuss updates. Some traders are noting unusual options activity, suggesting significant potential movement in either direction post-announcement.

Dogwood Therapeutics, Inc. is a development-stage biotechnology company, which engages in developing therapeutics for pain and fatigue illness. Its product includes Halneuron. It focuses on antiviral therapies IMC-1 and IMC-2 to treat diseases associated with a viral triggered abnormal immune response such as Long-COVID and fibromyalgia. The company was founded on February 28, 2012 is headquartered in Alpharetta, GA.

Dogwood Therapeutics Inc.

Dogwood Therapeutics is trending as traders discuss its low float and potential for a significant price surge, drawing comparisons to similar past runners. The community is closely watching for news related to upcoming Phase 2 data on Halneuron and potential partnerships for IMC-1, with some speculating on a potential squeeze due to limited shares available for borrowing.

JFB Construction Holdings is a commercial and residential real estate construction and development company, which engages in delivering services to commercial and residential markets. It operates through the following segments: Commercial Construction, Residential Construction, and Real Estate Development. The Commercial Construction segment includes all activities related to the construction of commercial properties. The Residential Construction segment focuses on the construction of residential properties including single-family homes and multi-family units. The Real Estate Development segment refers to the acquisition, development, and sale of real estate properties. The company was founded by Joseph F. Basille III on April 9, 2024 and is headquartered in Lantana, FL.

JFB Construction Holdings - Ordinary Shares - Class A

JFB is trending due to a recently announced private placement of approximately $44 million, sparking significant after-hours trading activity. The community is actively discussing the stock's potential for a short squeeze, noting its small float and high short interest. Some traders are also pointing to potential dilution from warrants associated with the private placement.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending following a Morgan Stanley downgrade, citing concerns about Alzheimer's trial risks, prescription trends, pricing pressures, and competition; however, the community is actively debating whether this downgrade is a strategic move to accumulate shares cheaply before positive news emerges, with some suggesting analysts are manipulating the stock for their benefit. While some express concern about the increased competition and potential margin squeeze, others emphasize the company's history of innovation and potential for long-term growth, particularly with its upcoming oral Wegovy and expansion into key markets like India.

Enanta Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery and development of small molecule drugs for the treatment of viral infections and liver diseases. It produces clinical candidates which targets respiratory syncytial virus (RSV), hepatitis B virus (HBV), and non-alcoholic steatohepatitis (NASH) diseases. The firm also conducts research in human metapneumovirus (hMPV) and SARS-CoV-2 (COVID-19). The company was founded by Peter O. Kliem Martin Karplus, James Hogle, Gerard Wagner, Peter M. Howley, and Gregory L. Verdine in 1995 and is headquartered in Watertown, MA.

Enanta Pharmaceuticals Inc

Enanta Pharmaceuticals ($ENTA) is trending as investors anticipate topline results from its Phase 2b study of Zelicapavir for RSV, expected to be released soon. Bullish sentiment is building, with some traders hoping for a significant price increase if the data proves positive. The community is actively seeking insights and analysis to gauge the potential outcome of the study.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USAR is trending due to news around potential government funding and strategic initiatives in the rare earth sector, including discussions of reallocating funds from the CHIPS Act. The community is actively discussing the implications of these developments, particularly in relation to domestic supply chains and competition with China. Some are also noting insider selling, as well as upcoming milestones for the company's magnet production and mine development.

SuperVerse is a unified Web3 ecosystem connecting gaming, DeFi, and AI under a single interoperable protocol. Its native token, $SUPER, powers transactions, governance, and access to immersive games, AI-powered tools, and liquidity infrastructure such as Blackhole DEX. Designed for real utility across multiple chains, $SUPER enables staking, protocol buybacks, and sustainable yield while supporting a growing suite of decentralized applications.

SuperFarm

SuperFarm is trending amidst community excitement and speculation about potential catalysts, with some pointing to gaming as a narrative. Bullish sentiment is fueled by observations of strong price action and technical analysis suggesting further upside. The community is actively discussing potential price targets and entry points as the coin experiences increased volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

French energy major TotalEnergies (TTE) said on Monday that it will sell half of its entire North American solar portfolio to private equity firm KKR &amp; Co for $950 million.The transaction encompasses six utility-scale solar assets with a combined capacity of 1.3 gigawatt (GW) and 41 distributed generation assets totaling 140 megawatt (MW), primarily located in the U.S. Total will retain the remaining stake and continue to operate it after the closing of the deal. The deal values the portfolio at an enterprise value of $1.25 billion.The move aligns with Total’s pledge to divest up to 50% of its renewable assets once they reach their commercial operation date and are de-risked. Last year, it sold half of its stake in a giant offshore wind farm in the UK.“Aligned with our strategy, this transaction unlocks value from newly commissioned assets and further strengthens the profitability of our Integrated Power business,” Stéphane Michel, President of Gas, Renewables &amp; Power at TotalEnergies, said in a statement. At the same time, KKR dubbed the assets as ‘high quality’ with long-term contracts.Retail sentiment on Stocktwits about <a href="https://stocktwits.com/symbol/TTE">TotalEnergies</a> was in the ‘neutral’ territory at the time of writing.<figure class="image"><img style="aspect-ratio:786/98;" src="https://news.stocktwits-cdn.com/TTE_Sept_29_JPG_f07b062848.webp" alt="TTE’s Sentiment Meter and Message Volume as of 03:37 a.m. ET on Sept. 29, 2025 | Source: Stocktwits" width="786" height="98"><figcaption>TTE’s Sentiment Meter and Message Volume as of 03:37 a.m. ET on Sept. 29, 2025 | Source: Stocktwits</figcaption></figure>The deal will help it pay down its debt, which soared to $26 billion as of June 30. The company has also pledged to slow share buybacks in 2026, citing economic conditions and the volatility in oil prices.Separately, Total said it plans to acquire a 49% interest in natural gas-producing assets owned and operated by Continental Resources in the Anadarko Basin, Oklahoma. Total, the third-largest player in the liquefied natural gas industry globally, stated that the assets could enable the company to produce 150 million cubic feet per day of natural gas.The acquisition follows two additional deals the company closed in the Eagle Ford Basin in the U.S., amid soaring demand for LNG in the country. The administration of President Donald Trump has encouraged more drilling and eased restrictions on the fossil fuel industry while curbing renewable energy projects.TotalEnergies' U.S. shares have gained 14.8% this year.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/honeywell-stock-flirts-with-death-cross-zone/chDMMs4R37l">Honeywell Stock Flirts With ‘Death Cross’ Zone — Retail Traders Remain Bearish</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

The brand logo of the energy company TotalEnergies SE can be seen at a filling station of the company near Prunelli-di-Fiumorbo on the island of Corsica.

TotalEnergies To Sell Half Of North America Solar Portfolio To KKR For $950M, Boosts US Natgas Assets

Total will retain the remaining stake and continue to operate it after the closing of the deal.

Equity

Sempra Energy (SRE) announced on Tuesday that it has agreed to sell a 45% stake in its Sempra Infrastructure Partners unit to affiliates of KKR (KKR) and the Canada Pension Plan Investment Board.&nbsp;<a href="http://stocktwits.com/symbol/SRE">Sempra’s stock</a> gained as much as 3.7% in pre-market trade. However, retail sentiment on Stocktwits remained in ‘neutral’ territory amid ‘high’ levels of chatter over the past day. Meanwhile,&nbsp;<a href="http://stocktwits.com/symbol/KKR">KKR’s stock</a> edged 0.2% lower, with retail sentiment on Stocktwits in ‘bearish’ territory amid ‘high’ levels of chatter.The sale of the Sempra Infrastructure Partners interest will help strengthen Sempra’s credit profile and improve its business mix “with a goal of approximately 95% earnings from regulated US utilities,” and it eliminates the need for previously announced equity issuances, the company said.&nbsp;The deal values Sempra Infrastructure Partners at an implied equity value of $22.2 billion and an enterprise value of $31.7 billion, with total proceeds of roughly $10 billion. Under the transaction terms, Sempra is expected to receive 47% of the cash at closing, 41% by the end of 2027, and the remaining balance about seven years after the deal closes.&nbsp;The company stated that this schedule enables it to “generate attractive post-closing interest income as it efficiently reinvests proceeds over time in capital expenditures at its U.S. utilities.”The company expects the deal to close in the second or third quarter of 2026. Upon completion, the KKR-led consortium will hold a majority 65% equity stake in Sempra Infrastructure Partners. Sempra will retain a 25% interest, while the Abu Dhabi Investment Authority maintains its existing 10% stake."The transactions announced today further Sempra's corporate strategy by advancing the company's capital recycling program and transition to a leading U.S. utility growth business," said Sempra CEO Jeffrey W. Martin.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/cryptocurrency/xrp-tops-altcoins-as-crypto-markets-stabilize-after-1-68-billion-futures-liquidation/chDhM3ZR353">XRP Tops Altcoins As Crypto Markets Stabilize After $1.68 Billion Futures Liquidation</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

General view of the Sempra building prior to a game between the San Francisco Giants and the San Diego Padres at PETCO Park on March 31, 2024 in San Diego, California. (Photo by Brandon Sloter/Getty Images)

Sempra To Sell 45% Stake In Infrastructure Unit To KKR In $10 Billion Deal

The deal is expected to close in the second or third quarter of 2026, leaving the KKR-led consortium with a 65% stake in Sempra Infrastructure Partners, Sempra with a 25% stake, and the Abu Dhabi Investment Authority retaining its 10% stake.

Carlyle Turnaround Halts $1T Merger Talks With Macquarie Group

CG's revival under CEO Harvey Schwartz ends merger talks with Macquarie that could have created a $1T alternatives giant.

JHG vs. KKR: Which Stock Is the Better Value Option?

Apollo vs. KKR & Co.: Which Asset Manager Offers More Upside Now?

Can APO's diversified model, strong inflows, and capital returns give it an edge over KKR in the race for future upside? Let us find out.

Private equity firm KKR &amp; Co. (KKR) raised its offer for UK-based Spectris to 4.2 billion euros ($5.6 billion) in its latest attempt to outbid rival buyout firm Advent.The new offer comes days after a bid from Advent, which the Spectris board had approved. The KKR offer values Spectris at 4.8 billion euros, including debt, and includes 41.75 pence in cash for each share of the company, along with an interim dividend of 28 pence for fiscal 2025.Over the past month, KKR has been battling for Spectris, a company that develops high-tech instruments, testing equipment, and software used in various sectors, including life sciences. The U.S.-based private equity firm said that Spectris commands such a valuation as it is an attractive asset, particularly after it trimmed costs and sold assets to focus on “higher quality businesses.”The latest offer implies a premium of 1.8% compared to Advent’s last offer, and more than double its share price since June 6, when media reports hinted at a potential deal. The Spectris board said it will back the offer.Retail sentiment on Stocktwits about <a href="https://stocktwits.com/symbol/KKR">KKR </a>was in the ‘bullish’ territory at the time of writing.<figure class="image"><img style="aspect-ratio:713/83;" src="https://news.stocktwits-cdn.com/KKR_new_Aug_5_JPG_625f467005.webp" alt="KKR’s Sentiment Meter and Message Volume as of 05:20 a.m. ET on Aug. 5, 2025 | Source: Stocktwits" width="713" height="83"><figcaption>KKR’s Sentiment Meter and Message Volume as of 05:20 a.m. ET on Aug. 5, 2025 | Source: Stocktwits</figcaption></figure>The relatively low valuation of UK companies and relative policy stability have attracted overseas buyers, such as KKR. The bidding war began after Spectris’ valuation halved compared to its 2021 peak.In the second quarter, KKR raised $28 billion of capital and noted that it “continues to see meaningful progress across asset classes.”KKR stock has slipped 2.8% this year, compared with 7.1% gains in the SPDR S&amp;P 500 ETF Trust (SPY).Also See: <a href="https://stocktwits.com/news-articles/markets/equity/caterpillar-q2-earnings-preview-trump-tariff-impact-and-power-equipment-business-in-focus/chrLm4XRdcw">Caterpillar Q2 Earnings Preview: Trump Tariff Impact And Power Equipment Business In Focus</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a person holds a smartphone displaying the logo of KKR & Co. Inc. 

KKR Boosts Spectris Takeover Bid To $5.6B In Buyout Battle With Advent

The KKR offer includes 41.75 pounds in cash for each share of the company, including an interim dividend of 28 pence for fiscal 2025.

The Zacks Analyst Blog Highlights Oracle, Disney and KKR

Oracle, Disney, and KKR post strong gains as cloud momentum, park revenues, and AUM growth fuel investor optimism.

Top Analyst Reports for Oracle, Walt Disney & KKR

Oracle, Disney, and KKR lead with strong cloud, parks, and AUM growth, but face margin and cost headwinds in 2025.

KKR Q2 Earnings Surpass Estimates as AUM Rises Y/Y, Stock Gains

KKR's Q2 earnings beat estimates as AUM hits $686B and fee-related earnings rise 17.4%, lifting the stock in the pre-market trading.

KKR & Co. (KKR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for KKR & Co. (KKR) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

KKR & Co., Inc. operates as an investment firm. It offers alternative asset management as well as capital markets and insurance solutions. The firm's business segments include Asset Management and Insurance Business. The Asset Management segment engages in providing private equity, real assets, credit and liquid strategies, capital markets, and principal activities. The Insurance Business segment offers retirement, life insurance and reinsurance solutions to clients across individual and institutional markets. The company was founded by Henry Kravis, George R. Roberts, and Jerome Kholberg on May 1, 1976 and is headquartered in New York, NY.

Current Price	$135.25
Prev Close	$135.66
Open	$136.57
Dividend Yield	0.47%
50-Day Moving Average	$143.01
Beta	1.75
Avg. Volume	3.14M
PE Ratio	64.27

52-Week High	$170.40
52-Week Low	$86.15
Market Capitalization	$119.4B
EPS (Annual)	$3.28
Price to Book	4.65
Revenue Per Employee	$4.75M
Enterprise Value/EBITDA	N/A

KKR
KKR & Co. Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest KKR News

KKR KKR & Co. Inc.